# Harvard Apparatus Regenerative Technology Inc. (HRGN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HRGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 224.2K | $ -7.03M | $ -3.92M | $ 199.0K | $ 1.06M |
| 2024 | $ 0 | $ -8.13M | $ 6.33M | $ 294.0K | $ 3.22M |
| 2023 | $ 0 | $ -9.76M | $ -7.51M | $ 48.0K | $ 1.65M |
| 2022 | $ 0 | $ -12.56M | $ -5.71M | $ 147.0K | $ 989.0K |
| 2021 | $ 0 | $ -9.48M | $ -3.12M | $ 169.0K | $ -3.03M |
| 2020 | $ 0 | $ -6.20M | $ -5.16M | $ 586.0K | $ 1.13M |
| 2019 | $ 0 | $ -10.75M | $ -7.99M | $ 191.0K | $ 1.09M |
| 2018 | $ 0 | $ -9.94M | $ -10.26M | $ 0 | $ 1.97M |
| 2017 | $ 0 | $ -16.05M | $ -15.02M | $ 0 | $ 3.42M |
| 2016 | $ 112.8K | $ -15.93M | $ -12.88M | $ 0 | $ 1.77M |
| 2015 | $ 165.7K | $ -16.43M | $ -10.34M | $ 0 | $ 8.39M |
| 2014 | $ 131.4K | $ -15.63M | $ -12.94M | $ 0 | $ 6.49M |
| 2013 | $ 31.3K | $ -12.54M | $ -11.35M | $ 0 | $ 14.57M |
| 2012 | $ 0 | $ -5.33M | $ -8.97M | $ 0 | $ 27.0K |
| 2011 | $ 0 | $ -1.84M | $ -5.55M | $ 0 | $ 22.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.19 |
| Liabilities / Eq | 1.53 |
| Current Ratio | 1.19 |

## Other views

- [Metrics](https://sponda.capital/en/HRGN.md)
- [Charts](https://sponda.capital/en/HRGN/charts.md)
- [Compare](https://sponda.capital/en/HRGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.